Vista de conjunto

Productos Roche S. A. Q. e I. – Tigre, Provincia de Buenos Aires – The Disesase Specialist Triple Negative Breast Cancer (DS TNBC) is responsible for leading and rolling out the SP142/PDL-1 project with the aim to accelerate the market access of SP142 as well as Tecentriq in the area of Triple Negative Breast Cancer. The DS TNBC is reporting to the Product Manager Oncology and driving the above mentioned activities in close collaboration between Roche Diagnostics and Roche Pharma. His/her mission is to: Ensure the implementation of the strategic and tactical plan for SP142/Tecentriq Build a solid network with Pathologists, Oncologists, insitutions and payers Map the stakeholder structure in a meaningful way that guarantees the development of an access plan in the public and private healthcare channel Keep all involved project members informed, focusing on the established and agreed objectives and thus, ensure that the defined action plan is implemented Collaborate and validate activities with the assigned Access Manager Identify opportunitie…